158 related articles for article (PubMed ID: 19497413)
1. The selenium analog of the chemopreventive compound S,S'-(1,4-phenylenebis[1,2-ethanediyl])bisisothiourea is a remarkable inducer of apoptosis and inhibitor of cell growth in human non-small cell lung cancer.
Das A; Bortner J; Desai D; Amin S; El-Bayoumy K
Chem Biol Interact; 2009 Jul; 180(2):158-64. PubMed ID: 19497413
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive effects of PBI-Se, a selenium-containing analog of PBIT, on AOM-induced aberrant crypt foci in F344 rats.
Janakiram NB; Mohammed A; Ravillah D; Choi CI; Zhang Y; Desai D; Amin S; Rao CV
Oncol Rep; 2013 Aug; 30(2):952-60. PubMed ID: 23708609
[TBL] [Abstract][Full Text] [Related]
3. PBISe, a novel selenium-containing drug for the treatment of malignant melanoma.
Madhunapantula SV; Desai D; Sharma A; Huh SJ; Amin S; Robertson GP
Mol Cancer Ther; 2008 May; 7(5):1297-308. PubMed ID: 18483317
[TBL] [Abstract][Full Text] [Related]
4. Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer.
El-Bayoumy K; Das A; Narayanan B; Narayanan N; Fiala ES; Desai D; Rao CV; Amin S; Sinha R
Carcinogenesis; 2006 Jul; 27(7):1369-76. PubMed ID: 16399772
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of a novel iNOS/Akt inhibitor Se,Se'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea (PBISe)--against colon cancer.
Desai D; Madhunapantula SV; Gowdahalli K; Sharma A; Chandagaludoreswamy R; El-Bayoumy K; Robertson GP; Amin S
Bioorg Med Chem Lett; 2010 Mar; 20(6):2038-43. PubMed ID: 20153642
[TBL] [Abstract][Full Text] [Related]
6. Chemopreventive effects of a selective nitric oxide synthase inhibitor on carcinogen-induced rat esophageal tumorigenesis.
Chen T; Nines RG; Peschke SM; Kresty LA; Stoner GD
Cancer Res; 2004 May; 64(10):3714-7. PubMed ID: 15150132
[TBL] [Abstract][Full Text] [Related]
7. Novel seleno- and thio-urea derivatives with potent in vitro activities against several cancer cell lines.
Alcolea V; Plano D; Karelia DN; Palop JA; Amin S; Sanmartín C; Sharma AK
Eur J Med Chem; 2016 May; 113():134-44. PubMed ID: 26922233
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.
Rao CV; Kawamori T; Hamid R; Reddy BS
Carcinogenesis; 1999 Apr; 20(4):641-4. PubMed ID: 10223193
[TBL] [Abstract][Full Text] [Related]
9. Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells.
Narayanan BA; Narayanan NK; Desai D; Pittman B; Reddy BS
Carcinogenesis; 2004 Dec; 25(12):2443-9. PubMed ID: 15297372
[TBL] [Abstract][Full Text] [Related]
10. Inducible nitric oxide synthase attenuates endothelium-dependent renal microvascular vasodilation.
Ichihara A; Hayashi M; Navar LG; Saruta T
J Am Soc Nephrol; 2000 Oct; 11(10):1807-1812. PubMed ID: 11004210
[TBL] [Abstract][Full Text] [Related]
11. Sanyang Xuedai enhances the radiosensitivity of human non-small cell lung cancer cells via increasing iNOS/NO production.
Wang L; Xia Y; Chen T; Zeng Y; Li L; Hou Y; Li W; Liu Z
Biomed Pharmacother; 2018 Jun; 102():618-625. PubMed ID: 29602129
[TBL] [Abstract][Full Text] [Related]
12. Melanoma prevention using topical PBISe.
Chung CY; Madhunapantula SV; Desai D; Amin S; Robertson GP
Cancer Prev Res (Phila); 2011 Jun; 4(6):935-48. PubMed ID: 21367959
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of mammary cancer chemoprevention by organoselenium compounds.
El-Bayoumy K; Sinha R
Mutat Res; 2004 Jul; 551(1-2):181-97. PubMed ID: 15225592
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 expression influences the growth of human large and small cell lung carcinoma lines in athymic mice: impact of an organoselenium compound on growth regulation.
El-Bayoumy K; Rose DP; Papanikolaou N; Leszczynska J; Swamy MV; Rao CV
Int J Oncol; 2002 Mar; 20(3):557-61. PubMed ID: 11836568
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
[TBL] [Abstract][Full Text] [Related]
16. Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells.
Zheng X; Xu W; Sun R; Yin H; Dong C; Zeng H
Chem Biol Interact; 2017 Sep; 275():74-85. PubMed ID: 28757135
[TBL] [Abstract][Full Text] [Related]
17. Enhanced sensitivity of human oral carcinomas to induction of apoptosis by selenium compounds: involvement of mitogen-activated protein kinase and Fas pathways.
Ghose A; Fleming J; El-Bayoumy K; Harrison PR
Cancer Res; 2001 Oct; 61(20):7479-87. PubMed ID: 11606383
[TBL] [Abstract][Full Text] [Related]
18. Chain elongation analog of resveratrol as potent cancer chemoprevention agent.
Kang YF; Qiao HX; Xin LZ; Ge LP
J Physiol Biochem; 2016 Sep; 72(3):445-52. PubMed ID: 27160168
[TBL] [Abstract][Full Text] [Related]
19. Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer.
Ye S; Yang W; Wang Y; Ou W; Ma Q; Yu C; Ren J; Zhong G; Shi H; Yuan Z; Su X; Zhu W
Int J Mol Med; 2013 Jan; 31(1):33-42. PubMed ID: 23128378
[TBL] [Abstract][Full Text] [Related]
20. A synthetic naringenin derivative, 5-hydroxy-7,4'-diacetyloxyflavanone-N-phenyl hydrazone (N101-43), induces apoptosis through up-regulation of Fas/FasL expression and inhibition of PI3K/Akt signaling pathways in non-small-cell lung cancer cells.
Bak Y; Kim H; Kang JW; Lee DH; Kim MS; Park YS; Kim JH; Jung KY; Lim Y; Hong J; Yoon DY
J Agric Food Chem; 2011 Sep; 59(18):10286-97. PubMed ID: 21877710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
